ALLELIC IMBALANCE IN MAMMARY CARCINOMAS INDUCED BY EITHER 7,12-DIMETHYLBENZ[A]ANTHRACENE OR IONIZING-RADIATION IN RATS CARRYING GENES CONFERRING DIFFERENTIAL SUSCEPTIBILITIES TO MAMMARY CARCINOGENESIS
Jd. Haag et al., ALLELIC IMBALANCE IN MAMMARY CARCINOMAS INDUCED BY EITHER 7,12-DIMETHYLBENZ[A]ANTHRACENE OR IONIZING-RADIATION IN RATS CARRYING GENES CONFERRING DIFFERENTIAL SUSCEPTIBILITIES TO MAMMARY CARCINOGENESIS, Molecular carcinogenesis, 17(3), 1996, pp. 134-143
To identify and compare the genetic lesions associated with tumorigene
sis in rats carrying the mammary carcinoma suppressor (MCS) 1 gene, we
induced mammary carcinomas in (Wistar Furth (WF) x Copenhagen (Cop))F
-1 rats by using either 7,1 2-dimethylbenz[a]anthracene (DMBA) or radi
ation. The tumors were screened for allelic imbalances by using polyme
rase chain reaction and 65 polymorphic microsatellite markers spanning
the genome. No allelic imbalance was detected at the mapped location
of MCS-1 on chromosome 2; however, a scan of the genome revealed rando
m allelic imbalances in the radiation-induced tumors. In addition, non
random loss of heterozygosity (LOH) on chromosome 1 in the DMBA-induce
d tumors was documented. We then screened three other subsets of DMBA-
and radiation-induced mammary carcinomas from (WF x Fischer (F344))F-
1, (Wistar KyotoxF344)F-1, and (F344xCop)F-1 rats for imbalance on chr
omosomes 1 and 2. No allelic imbalance was detected in the MCS-1 regio
n of chromosome 2 in any of the tumors screened. Nonrandom imbalance o
n chromosome 1 was detected but only in the DMBA-induced tumors from t
he (F344xCop)F-1 rats. Thus, only Cop-derived F-1 rats have mammary tu
mors with the chromosome 1 imbalance; however, the imbalance does not
favor the Cop parental allele. We also analyzed the DMBA-induced tumor
s with LOH at chromosome 1 for Ha-ras codon 61 mutation and found no a
ssociation. These results suggest that loss of the MCS-1 Cop allele is
not required for tumor formation, that the genetic background of the
F-1 rat appears to influence the type of genetic lesion identified in
the mammary tumors, and that there is no association between Ha-ras co
don 61 mutation and chromosome 1 imbalance in our model system. (C) 19
96 Wiley-Liss, Inc.